Shuang F. Huang
No. 270, Dong An Rd
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Artificial intelligence-enabled "inherited noninvasive intracellular recording" for prolonged monitoring of cardiac action potentials.
Journal: Science advances
Published: January 16, 2026
Penpulimab and Gemcitabine With or Without Anlotinib in Metastatic Nasopharyngeal Carcinoma: A Randomized, Open-Label, Multicenter Phase 2 Study.
Journal: International journal of cancer
Published: November 06, 2025
Recombinant Human Thrombopoietin Combined With Avatrombopag for Chemoradiotherapy-Induced Thrombocytopenia in Nasopharyngeal Carcinoma: A Prospective, Randomized Controlled Trial.
Journal: British journal of hospital medicine (London, England : 2005)
Published: September 25, 2025
Efficacy of PD-1 inhibitor plus induction chemotherapy for nasopharyngeal carcinoma with high-grade extranodal extension: a multicenter retrospective analysis.
Journal: BMC cancer
Published: September 17, 2025
Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 study.
Journal: Signal transduction and targeted therapy
Published: August 12, 2025
Effects of Antibiotics on First-line Immunotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: February 05, 2025
Concurrent chemotherapy for older patients with locoregionally advanced nasopharyngeal carcinoma: A randomized clinical trial.
Journal: Journal of geriatric oncology
Published: December 01, 2024
Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma.
Journal: Neoplasia (New York, N.Y.)
Published: October 11, 2024
Mecapegfilgrastim for the prophylaxis of chemotherapy-induced neutropenia in locally advanced nasopharyngeal carcinoma: A prospective phase II clinical study.
Journal: Head & neck
Published: April 08, 2024
Concurrent nimotuzumab and intensity-modulated radiotherapy for elderly patients with locally advanced nasopharyngeal carcinoma.
Journal: Cancer science
Published: February 24, 2024
Long-term efficacy analysis of radiotherapy and local management of metastases in patients with newly diagnosed oligometastatic nasopharyngeal carcinoma: A prospective, single-arm, single-center clinical study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 02, 2023
Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma: a single-arm phase II study.
Journal: Signal transduction and targeted therapy
Published: November 01, 2023
Last Updated: 09/26/2026